Associate Professor David Whiley is a Principal Research Fellow at The University of Queensland Centre for Clinical Research (UQCCR) and Senior Research Scientist at Pathology Queensland. Their work focuses on the diagnosis and characterisation of infectious diseases and associated antimicrobial resistance. They have over 240 journal publications and in the last five years has been Chief Investigator on numerous grants all of which have been aimed at improving diagnosis and treatment of STIs, these include: Queensland Advancing Clinical Research Fellowships (2020-2023, CIA), NHMRC project grant (2017-2020, CIA), NHMRC synergy grant (2020-2024, CIF), a NHMRC CRE (2018-2022, CIF), and an ARC Industrial Transformation Research Hub (2020-2024, CIC).

A/Prof Whiley has a solid track record of translating research into practice and has played a pivotal role in development of molecular diagnostic methods in Australia. These assays are routinely used by clinical laboratories throughout Australia and elsewhere. A/Prof Whiley has also made significant contributions to understanding the genetic basis of Neisseria gonorrhoeae antimicrobial resistance and working with industry partner SpeeDx Pty Ltd developed the first commercial rapid molecular test for N. gonorrhoeae AMR. A/Prof Whiley is regularly consulted as an expert in molecular diagnostics, including by the WHO and has been a long-time member of the National Neisseria Network.

Publications by David Whiley